{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T03:48:15Z","timestamp":1773200895442,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2009,6,3]],"date-time":"2009-06-03T00:00:00Z","timestamp":1243987200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1007\/s00403-009-0967-1","type":"journal-article","created":{"date-parts":[[2009,6,2]],"date-time":"2009-06-02T08:54:55Z","timestamp":1243932895000},"page":"689-692","source":"Crossref","is-referenced-by-count":23,"title":["Immunochemotherapy for Bcl-2 and MUM-negative aggressive primary cutaneous B-cell non-Hodgkin\u2019s lymphoma"],"prefix":"10.1007","volume":"301","author":[{"given":"Natasa","family":"Colovic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Jurisic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatjana","family":"Terzic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry Dushan","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milica","family":"Colovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,6,3]]},"reference":[{"key":"967_CR1","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1182\/blood-2005-01-0140","volume":"106","author":"A Altieri","year":"2005","unstructured":"Altieri A, Lorenzo Bermejo J, Hemminki K (2005) Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database. Blood 106:668\u2013672. doi: 10.1182\/blood-2005-01-0140","journal-title":"Blood"},{"issue":"10","key":"967_CR2","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.0303-6987.2005.00495.x","volume":"32","author":"G Burg","year":"2005","unstructured":"Burg G, Kempf W, Cozzio A, Feit J, Willemze R, Jaffe E, Dummer R, Berti E, Cerroni L, Chimenti S, Diaz-Perez JL, Grange F, Harris NL, Kazakov DV, Kerl H, Kurrer M, Knobler R, Meijer CJ, Pimpinelli N, Ralfkiaer E, Russell-Jones R, Sander C, Santucci M, Sterry W, Swerdlow SH, Vermeer MH, Wechsler J, Whittaker S (2005) WHO\/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects. J Cutan Pathol 32(10):647\u2013674. doi: 10.1111\/j.0303-6987.2005.00495.x","journal-title":"J Cutan Pathol"},{"key":"967_CR3","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1182\/blood-2003-08-2726","volume":"103","author":"F Grange","year":"2004","unstructured":"Grange F, Petrella T, Beylot-Barry M et al (2004) Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas. Blood 103:3662\u20133668. doi: 10.1182\/blood-2003-08-2726","journal-title":"Blood"},{"key":"967_CR4","volume-title":"World Health Organization Classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues","year":"2001","unstructured":"Jaffe ES, Harris NL, Stein H, Vardiman JWE (eds) (2001) World Health Organization Classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon, PA"},{"key":"967_CR5","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1046\/j.1365-2141.1999.01129.x","volume":"104","author":"G Konjevic","year":"1999","unstructured":"Konjevic G, Jurisic V, Banicevic B, Spuzic I (1999) Difference in NK cell activity between patients with non-Hodgkin\u2019s lymphoma and Hodgkin\u2019s disease. Br J Haematol 104:144\u2013151. doi: 10.1046\/j.1365-2141.1999.01129.x","journal-title":"Br J Haematol"},{"key":"967_CR6","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1200\/JCO.2000.18.10.2152","volume":"18","author":"TL Pandolfino","year":"2000","unstructured":"Pandolfino TL, Siegel RS, Kuzel TM, Rosen ST, Guitart J (2000) Primary cutaneous B cell lymphoma: review and current concepts. J Clin Oncol 18:2152\u20132168","journal-title":"J Clin Oncol"},{"key":"967_CR7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0360-3016(93)90251-P","volume":"27","author":"R Piccino","year":"1993","unstructured":"Piccino R, Caccialanza M, Berti E, Baldini L (1993) Radiotherapy of cutaneous B-cell lymphoma. Int J Radiat Oncol Biol Phys 27:385\u2013389","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"967_CR8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1365-2133.2000.03607.x","volume":"143","author":"RA Sabroe","year":"2000","unstructured":"Sabroe RA, Child FJ, Woolford AJ, Spittle M, Russel-Jones R (2000) Rituximab in cutaneous B-cell lymphoma: report of two cases. Br Dermatol 143:157. doi: 10.1046\/j.1365-2133.2000.03607.x","journal-title":"Br Dermatol"},{"key":"967_CR9","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1002\/1097-0142(19910501)67:9<2311::AID-CNCR2820670918>3.0.CO;2-0","volume":"67","author":"M Santucci","year":"1991","unstructured":"Santucci M, Pimpinelli N, Arganini L (1991) Primary cutaneous B cell lymphoma: a unique type of low grade lymphoma. Cancer 67:2311\u20132326. doi: 10.1002\/1097-0142(19910501)67:9<2311::AID-CNCR2820670918>3.0.CO;2-0","journal-title":"Cancer"},{"issue":"2","key":"967_CR10","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1200\/JCO.2001.19.2.398","volume":"19","author":"AH Sarris","year":"2001","unstructured":"Sarris AH, Braunschweig I, Medeiros LJ, Duvic M, Ha CS, Roodriquez AM, Hagemeister FB, McLaughlin P, Romaguera J, Cox J, Cabanillas F (2001) Primary cutaneous non-Hodgkin\u2019s lymphoma of Ann Arbor Stage I: preferential cutaneous relapses but high cure rate with doxorubicin-based therapy. J Clin Oncol 19(2):398\u2013405","journal-title":"J Clin Oncol"},{"key":"967_CR11","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/annonc\/mdf206","volume":"13","author":"C Visco","year":"2002","unstructured":"Visco C, Medeiros LJ, Jones D, Smith T, Rodriguez MA, McLaughlin P, Romaguera J, Cabanillas F, Sarris HA (2002) Primary cutaneous non-Hodgkin\u2019s lymphoma with aggressive histology: inferior outcome is associated with peripheral T-cell type and elevated lactate dehydrogenase, but not extent of cutaneous involvement. Ann Oncol 13:1290\u20131299. doi: 10.1093\/annonc\/mdf206","journal-title":"Ann Oncol"},{"key":"967_CR12","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","volume":"105","author":"R Willemze","year":"2005","unstructured":"Willemze R, Jaffe SE, Burg G, Ceroni L, Berti E, Swerdow SH, Ralfkiaer E, Chimenti S, Diaz-Perez JL, Dunkan LM, Grange F, Harris Lee N, Kempf W, Kerl H, Kurrer M, Knobler R, Pimpinelli N, Sander C, Santucci M, Sterry W, Wermeer MH, Wechler J, Whittaker S, Meijr JLMC (2005) WHO-EORTC classification for cutaneous lymphoma. Blood 105:3768\u20133785. doi: 10.1182\/blood-2004-09-3502","journal-title":"Blood"},{"key":"967_CR13","first-page":"354","volume":"90","author":"R Willemze","year":"1997","unstructured":"Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S, Diaz-Perez JL, Geerts ML, Goos M, Knobler R, Ralfkiaer E, Santucci M, Smith N, Wechsler J, van Vloten WA, Meijer CJ (1997) EORTC classification for primary cutaneous lymphomas: a proposal from the cutaneous lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 90:354\u2013371","journal-title":"Blood"},{"key":"967_CR14","first-page":"219","volume":"11","author":"E Zucca","year":"2000","unstructured":"Zucca E, Cavalli F (2000) Extranodal lymphomas. Ann Oncol 11:219\u2013222. doi: 10.1023\/A:1011104821629","journal-title":"Ann Oncol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-009-0967-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-009-0967-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-009-0967-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T17:37:41Z","timestamp":1559065061000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-009-0967-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,3]]},"references-count":14,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["967"],"URL":"https:\/\/doi.org\/10.1007\/s00403-009-0967-1","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,3]]}}}